← Back to Search

NRT + QuitBuddy-Recall for Smoking Cessation

N/A
Waitlist Available
Led By Bryan W Heckman, PhD
Research Sponsored by Meharry Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
at least 18 years of age
daily cigarette smoker of > 9 cigarettes/day for past year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights
No Placebo-Only Group

Study Summary

This study is evaluating whether a smartphone app can help people quit smoking.

Eligible Conditions
  • Smoking Cessation

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Abstinence from cigarettes

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: NRT + QuitBuddy-RecallExperimental Treatment1 Intervention
This smartphone app will identify high-risk situations through retrospective recall of locations where the patient typically smoked. Hotspot maps will provide interactive visualizations of relapse risk. GPS triggered NRT/behavioral prompts will occur when participants come within 50m from the centroid of a hotspot.
Group II: NRT + QuitBuddyExperimental Treatment1 Intervention
This smartphone app will identify high-risk situations through real-time EMA data collected before and during a quit attempt. One week of pre-quit smoking behaviors will be integrated with passively sensed GPS data to create hotspot maps. Hotspot maps will provide interactive visualizations of relapse risk. GPS triggered NRT/behavioral prompts will occur when participants come within 50m from the centroid of a hotspot.
Group III: NRT Control (treatment as usual)Active Control1 Intervention
Standard Care Control is intended to approximate the real-world experience where smokers obtain over-the-counter NRT and, after brief instructions at the outset (~1 lozenge per hour, during cravings, and <20 per day), determine usage for themselves.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,426 Previous Clinical Trials
2,403,404 Total Patients Enrolled
Medical University of South CarolinaOTHER
921 Previous Clinical Trials
7,366,552 Total Patients Enrolled
Meharry Medical CollegeLead Sponsor
18 Previous Clinical Trials
5,890 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Feb 2025